The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
TJ-107 for the prevention of oxaliplatin-induced peripheral neuropathy: Results of a phase II randomized placebo-controlled clinical trial.
Toru Kono
No relevant relationships to disclose
Taishi Hata
No relevant relationships to disclose
Yoshinori Munemoto
No relevant relationships to disclose
Takanori Matsui
No relevant relationships to disclose
Hiroshi Kojima
No relevant relationships to disclose
Hiroyoshi Takemoto
No relevant relationships to disclose
Mutsumi Fukunaga
No relevant relationships to disclose
Mitsuo Shimada
No relevant relationships to disclose
Naoki Nagata
No relevant relationships to disclose
Satoshi Morita
No relevant relationships to disclose
Junichi Sakamoto
No relevant relationships to disclose
Hideyuki Mishima
No relevant relationships to disclose